Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2

Oman J Ophthalmol. 2022 Nov 2;15(3):393-396. doi: 10.4103/ojo.ojo_4_22. eCollection 2022 Sep-Dec.

Abstract

A 62-year-old man presented with complaints of decreased vision in BE. His best-corrected visual acuity (BCVA) was 6/12 in both eyes (BE). Based on his fundus examination and imaging findings, he was diagnosed with BE Macular Telangiectasia type 2 (MacTel 2) and was advised of regular follow-up. Over the course of follow-up, he developed further reduction in vision in the right eye (RE) to 6/24. Spectral-domain optical coherence tomography (SD-OCT) showed the presence of a subfoveal detachment (SFD) with intraretinal cystoid edema. He was diagnosed to have an exudative variant of preproliferative MacTel 2 and underwent three intravitreal injections of bevacizumab in the RE following which there was an improvement in BCVA to 6/12 along with the complete resolution of SFD and IRF on SD-OCT. This report describes a rare case of exudative nonproliferative macular telangiectasia type 2 presenting with the presence of intraretinal fluid.

Keywords: Bevazizumab; exudative nonproliferative macular telangiectasia type 2; intraretinal fluid; subfoveal detachment.

Publication types

  • Case Reports